The aim of our study was to investigate responses of FGF19 and bile acid (BA) synthesis after a body weight-adjusted oral fat tolerance test (OFTT) in overweight and obese NAFLD patients. This evidence concerns the gene FGF19 and metabolic dysfunction-associated steatotic liver disease.